Leadless Implantable Electroacupuncture Device Power Management

The patent extracts and eliminates the needles and long insulated wires from the electroacupuncture system. Instead, it uses a leadless implantable device with electrodes directly integrated into the housing, which is implanted subcutaneously near the target acupoint. This removes the invasive needle insertion and complex wire implantation while maintaining electrical stimulation capability through the integrated electrodes.

The patent merges the electrical stimulation delivery function directly into the implantable device housing. The electrodes are integrated into the housing structure itself, combining the stimulator body and electrode contacts into a single unified unit. This eliminates the need for separate needles and wires, reducing device complexity and invasiveness while maintaining therapeutic effectiveness.

The patent employs periodic pulsed electrical stimulation instead of continuous stimulation. The device delivers controlled pulses of electrical energy at specific intervals, which reduces overall power consumption while maintaining therapeutic effectiveness. This periodic action allows the small coin-cell battery to provide sufficient energy for the required treatment duration without requiring a larger power supply.

The patent optimizes the electrical stimulation parameters (pulse width, amplitude, frequency, and duty cycle) to match the specific requirements of electroacupuncture therapy. By carefully selecting and adjusting these parameters, the device achieves effective tissue stimulation with minimal energy consumption, enabling the use of a small battery in a compact form factor.

The patent uses intermittent pulsed stimulation with defined duty cycles rather than continuous stimulation. The electrical pulses are delivered in periodic sequences with active stimulation phases followed by rest periods. This periodic action maintains therapeutic effectiveness by delivering sufficient total energy while allowing thermal dissipation during rest periods, thereby minimizing heat generation in the target tissue.

The patent achieves continuous therapeutic effect through high-frequency pulsing within the stimulation window. Although the overall stimulation is intermittent, the pulses within each active phase are delivered at frequencies that maintain continuous physiological effect on the target tissue. This approach ensures therapeutic continuity while limiting total energy delivery to prevent excessive heat generation.